<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font21 { font-size : 21; } .font24 { font-size : 24; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">FFAR </span>
   <span class="font24">breast </span>
   <span class="font21">cancer </span>
   <span class="font16">fatty </span>
   <span class="font15">acid </span>
   <span class="font14">cells </span>
   <span class="font14">patients </span>
   <span class="font14">HRPBC </span>
   <span class="font13">(.–.) </span>
   <span class="font13">expression </span>
   <span class="font13">ligands </span>
   <span class="font13">tissues </span>
   <span class="font13">tamoxifen </span>
   <span class="font13">receptor </span>
   <span class="font13">Cancer </span>
   <span class="font12">acids </span>
   <span class="font12">human </span>
   <span class="font12">prognostic </span>
   <span class="font12">resistance </span>
   <span class="font12">cohort </span>
   <span class="font12">hormone </span>
   <span class="font12">normal </span>
   <span class="font12">cell </span>
   <span class="font12">different </span>
   <span class="font12">endogenous </span>
   <span class="font12">staining </span>
   <span class="font12">survival </span>
   <span class="font12">{border-style </span>
   <span class="font11">cancerous </span>
   <span class="font11">AKT </span>
   <span class="font11">clinical </span>
   <span class="font11">compared </span>
   <span class="font11">px;} </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">Res </span>
   <span class="font11">(Fig. </span>
   <span class="font11">MCF- </span>
   <span class="font11">status </span>
   <span class="font11">tumor </span>
   <span class="font11">ERK </span>
   <span class="font11">value </span>
   <span class="font11">ER-positive </span>
   <span class="font11">RFS </span>
   <span class="font11">exploration </span>
   <span class="font11">patients. </span>
   <span class="font11">results </span>
   <span class="font11">signaling </span>
   <span class="font11">significantly </span>
   <span class="font11">used </span>
   <span class="font11">( μM) </span>
   <span class="font11">Breast </span>
   <span class="font11">Fig. </span>
   <span class="font11">GPR </span>
   <span class="font11">TUG </span>
   <span class="font11">estrogen </span>
   <span class="font11">showed </span>
   <span class="font11">tissues. </span>
   <span class="font11">Cell </span>
   <span class="font11">E-MTAB- </span>
   <span class="font11">HER </span>
   <span class="font11">associated </span>
   <span class="font11">data </span>
   <span class="font11">ligand </span>
   <span class="font11">mRNA </span>
   <span class="font11">receptor-positive </span>
   <span class="font11">synthetic </span>
   <span class="font11">treated </span>
   <span class="font11">viability </span>
   <span class="font11">FFAR-low </span>
   <span class="font11">H-score </span>
   <span class="font11">elevated </span>
   <span class="font11">independent </span>
   <span class="font11">n = ) </span>
   <span class="font11">proportions </span>
   <span class="font11">receptor-negative </span>
   <span class="font11">recurrence </span>
   <span class="font11">tissue </span>
   <span class="font11">treatment </span>
   <span class="font11">using </span>
   <span class="font11">vs. </span>
   <span class="font11">P = .; </span>
   <span class="font11">Table </span>
   <span class="font11">Tumor </span>
   <span class="font11">disease </span>
   <span class="font11">effects </span>
   <span class="font11">file </span>
   <span class="font11">negative </span>
   <span class="font11">studies </span>
   <span class="font11">study </span>
   <span class="font11">time </span>
   <span class="font11">tissues, </span>
   <span class="font10">DHA </span>
   <span class="font10">FFAR’s </span>
   <span class="font10">Fatty </span>
   <span class="font10">indicate </span>
   <span class="font10">statistical </span>
   <span class="font10">tamoxifen’s </span>
   <span class="font10">validation </span>
   <span class="font10">worse </span>
   <span class="font10">Additional </span>
   <span class="font10">Age </span>
   <span class="font10">China </span>
   <span class="font10">Clin </span>
   <span class="font10">FFAR-induced </span>
   <span class="font10">GSE </span>
   <span class="font10">IHC </span>
   <span class="font10">Luminal </span>
   <span class="font10">cancer-specific </span>
   <span class="font10">characteristics </span>
   <span class="font10">employed </span>
   <span class="font10">endocrine </span>
   <span class="font10">higher </span>
   <span class="font10">identified </span>
   <span class="font10">indicated </span>
   <span class="font10">knockdown </span>
   <span class="font10">mass </span>
   <span class="font10">n = ). </span>
   <span class="font10">phosphorylation </span>
   <span class="font10">positive </span>
   <span class="font10">profiles </span>
   <span class="font10">px; </span>
   <span class="font10">{font-family </span>
   <span class="font10">-well </span>
   <span class="font10">BCSS </span>
   <span class="font10">GC-MS </span>
   <span class="font10">Grade </span>
   <span class="font10">OHT </span>
   <span class="font10">XC, </span>
   <span class="font10">adipose </span>
   <span class="font10">analysis </span>
   <span class="font10">cells. </span>
   <span class="font10">cohort, </span>
   <span class="font10">cohorts </span>
   <span class="font10">diagnosis </span>
   <span class="font10">distribution </span>
   <span class="font10">factor </span>
   <span class="font10">font-size </span>
   <span class="font10">free </span>
   <span class="font10">pathways </span>
   <span class="font10">patients, </span>
   <span class="font10">performed </span>
   <span class="font10">potential </span>
   <span class="font10">prognosis </span>
   <span class="font10">receptors </span>
   <span class="font10">role </span>
   <span class="font10">seeded </span>
   <span class="font10">shown </span>
   <span class="font10">spectra </span>
   <span class="font10">tamoxifen-treated </span>
   <span class="font10">test </span>
   <span class="font10">therapy </span>
   <span class="font10">total </span>
   <span class="font10">variable </span>
   <span class="font10">(%) </span>
   <span class="font10">(.%) </span>
   <span class="font10">(positive </span>
   <span class="font10">.–., </span>
   <span class="font10">ER-negative </span>
   <span class="font10">FAME </span>
   <span class="font10">Figure </span>
   <span class="font10">Funding </span>
   <span class="font10">HR: </span>
   <span class="font10">Oncol </span>
   <span class="font10">P = .) </span>
   <span class="font10">Research </span>
   <span class="font10">Science </span>
   <span class="font10">Shanghai </span>
   <span class="font10">T-D </span>
   <span class="font10">Technology </span>
   <span class="font10">[])   </span>
   <span class="font10">acid, </span>
   <span class="font10">adipocytes </span>
   <span class="font10">antagonist </span>
   <span class="font10">association </span>
   <span class="font10">based </span>
   <span class="font10">cases. </span>
   <span class="font10">cells, </span>
   <span class="font10">classified </span>
   <span class="font10">concentrations </span>
   <span class="font10">demonstrated </span>
   <span class="font10">dependent </span>
   <span class="font10">double; </span>
   <span class="font10">efficacy </span>
   <span class="font10">expressed </span>
   <span class="font10">gene </span>
   <span class="font10">growth </span>
   <span class="font10">induced </span>
   <span class="font10">levels </span>
   <span class="font10">long-chain </span>
   <span class="font10">microarray </span>
   <span class="font10">molecular </span>
   <span class="font10">negative) </span>
   <span class="font10">observed </span>
   <span class="font10">outcome </span>
   <span class="font10">phenotype </span>
   <span class="font10">plates </span>
   <span class="font10">polyunsaturated </span>
   <span class="font10">properties </span>
   <span class="font10">reported </span>
   <span class="font10">risk </span>
   <span class="font10">serum </span>
   <span class="font10">serve </span>
   <span class="font10">significant </span>
   <span class="font10">therapeutic </span>
   <span class="font10">(high </span>
   <span class="font10">.%; </span>
   <span class="font10">CI: </span>
   <span class="font10">Department </span>
   <span class="font10">FFAR-high </span>
   <span class="font10">Free </span>
   <span class="font10">Furthermore, </span>
   <span class="font10">Gas </span>
   <span class="font10">HRPBC. </span>
   <span class="font10">Key </span>
   <span class="font10">Nat </span>
   <span class="font10">PUFA </span>
   <span class="font10">Soochow </span>
   <span class="font10">[], </span>
   <span class="font10">abrogated </span>
   <span class="font10">activation </span>
   <span class="font10">added </span>
   <span class="font10">adjuvant </span>
   <span class="font10">analyses </span>
   <span class="font10">analyzed </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">carcinoma </span>
   <span class="font10">confirmed </span>
   <span class="font10">continuous </span>
   <span class="font10">datasets </span>
   <span class="font10">described </span>
   <span class="font10">evaluated </span>
   <span class="font10">groups </span>
   <span class="font10">high: </span>
   <span class="font10">line </span>
   <span class="font10">lines </span>
   <span class="font10">lung </span>
   <span class="font10">measured </span>
   <span class="font10">novel </span>
   <span class="font10">n = ), </span>
   <span class="font10">patient </span>
   <span class="font10">previously </span>
   <span class="font10">provide </span>
   <span class="font10">recent </span>
   <span class="font10">remained </span>
   <span class="font10">resistant </span>
   <span class="font10">significance </span>
   <span class="font10">size </span>
   <span class="font10">solid; </span>
   <span class="font10">standard </span>
   <span class="font10">subtypes </span>
   <span class="font10">women </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10"> Negative </span>
   <span class="font10"> Positive </span>
   <span class="font10"> °C </span>
   <span class="font10">(&amp;gt;  cm </span>
   <span class="font10">(Table </span>
   <span class="font10">Aberrant </span>
   <span class="font10">Biophys </span>
   <span class="font10">C:n- </span>
   <span class="font10">Cells </span>
   <span class="font10">DGLA </span>
   <span class="font10">Hormone </span>
   <span class="font10">Hospital </span>
   <span class="font10">Jiangsu </span>
   <span class="font10">Jiao </span>
   <span class="font10">National </span>
   <span class="font10">Nature </span>
   <span class="font10">Normal </span>
   <span class="font10">Oncogene </span>
   <span class="font10">Rev </span>
   <span class="font10">Tong </span>
   <span class="font10">Wang </span>
   <span class="font10">Zhang </span>
   <span class="font10">according </span>
   <span class="font10">affect </span>
   <span class="font10">agonist </span>
   <span class="font10">analysis, </span>
   <span class="font10">available </span>
   <span class="font10">binary </span>
   <span class="font10">bold </span>
   <span class="font10">cancer. </span>
   <span class="font10">cases </span>
   <span class="font10">cohort. </span>
   <span class="font10">cohorts. </span>
   <span class="font10">colorectal </span>
   <span class="font10">confers </span>
   <span class="font10">considered </span>
   <span class="font10">continuous, </span>
   <span class="font10">contribute </span>
   <span class="font10">courier; </span>
   <span class="font10">datasets. </span>
   <span class="font10">death </span>
   <span class="font10">deaths </span>
   <span class="font10">developed </span>
   <span class="font10">differences </span>
   <span class="font10">effect </span>
   <span class="font10">effect. </span>
   <span class="font10">em; </span>
   <span class="font10">events </span>
   <span class="font10">future </span>
   <span class="font10">identification </span>
   <span class="font10">impact </span>
   <span class="font10">including </span>
   <span class="font10">inhibitor </span>
   <span class="font10">investigated </span>
   <span class="font10">ligands, </span>
   <span class="font10">lipid </span>
   <span class="font10">low) </span>
   <span class="font10">lower </span>
   <span class="font10">manuscript. </span>
   <span class="font10">marker </span>
   <span class="font10">mechanisms </span>
   <span class="font10">mediated </span>
   <span class="font10">methyl </span>
   <span class="font10">microenvironment </span>
   <span class="font10">moderately </span>
   <span class="font10">non-luminal </span>
   <span class="font10">optimal </span>
   <span class="font10">pathological </span>
   <span class="font10">pathways. </span>
   <span class="font10">pt;} </span>
   <span class="font10">rapid </span>
   <span class="font10">recurrences, </span>
   <span class="font10">remains </span>
   <span class="font10">resistance, </span>
   <span class="font10">sections </span>
   <span class="font10">selected </span>
   <span class="font10">shRNA </span>
   <span class="font10">situ </span>
   <span class="font10">spectrometry </span>
   <span class="font10">subtype </span>
   <span class="font10">types </span>
   <span class="font10">underlying </span>
   <span class="font10">uniformly </span>
   <span class="font10">vs ≤  cm) </span>
   <span class="font10">weakly </span>
  </p>
 </body>
</html>
